• 제목/요약/키워드: Korean Oncology

검색결과 6,315건 처리시간 0.035초

Development of new on-line statistical program for the Korean Society for Radiation Oncology

  • Song, Si Yeol;Ahn, Seung Do;Chung, Weon Kuu;Shin, Kyung Hwan;Choi, Eun Kyung;Cho, Kwan Ho
    • Radiation Oncology Journal
    • /
    • 제33권2호
    • /
    • pp.142-148
    • /
    • 2015
  • Purpose: To develop new on-line statistical program for the Korean Society for Radiation Oncology (KOSRO) to collect and extract medical data in radiation oncology more efficiently. Materials and Methods: The statistical program is a web-based program. The directory was placed in a sub-folder of the homepage of KOSRO and its web address is http://www.kosro.or.kr/asda. The operating systems server is Linux and the webserver is the Apache HTTP server. For database (DB) server, MySQL is adopted and dedicated scripting language is the PHP. Each ID and password are controlled independently and all screen pages for data input or analysis are made to be friendly to users. Scroll-down menu is actively used for the convenience of user and the consistence of data analysis. Results: Year of data is one of top categories and main topics include human resource, equipment, clinical statistics, specialized treatment and research achievement. Each topic or category has several subcategorized topics. Real-time on-line report of analysis is produced immediately after entering each data and the administrator is able to monitor status of data input of each hospital. Backup of data as spread sheets can be accessed by the administrator and be used for academic works by any members of the KOSRO. Conclusion: The new on-line statistical program was developed to collect data from nationwide departments of radiation oncology. Intuitive screen and consistent input structure are expected to promote entering data of member hospitals and annual statistics should be a cornerstone of advance in radiation oncology.

Detection of Circulating Melanoma Cells by a Two-marker Polymerase Chain Reaction Assay in Relation to Therapy

  • Bitisik, Ozlem;Camlica, Hakan;Duranyildiz, Derya;Tas, Faruk;Kurul, Sidika;Dalay, Nejat
    • BMB Reports
    • /
    • 제36권2호
    • /
    • pp.173-178
    • /
    • 2003
  • Malignant melanoma is one of the most rapidly increasing cancer types, and patients with metastatic disease have a very poor prognosis. Detection of metastatic melanoma cells in circulation may aid the clinician in assessing tumor progression, metastatic potential, and response to therapy. Tyrosinase is a key enzyme in melanine biosynthesis. The gene is actively expressed in melanocytes and melanoma cells. Melan A is a differentiation antigen that is expressed in melanocytes. The presence of these molecules in blood is considered a marker for circulating melanoma cells. In this study, we analyzed the usefulness of this marker combination I evaluating the response to therapy in the blood of 30 patients with malignant melanoma. Circulating cells were detected by a reverse-transcriptase-polymerase-chain reaction. The tyrosinase expression was observed in 9 (30%) patients and Melan A in 19 (63.3%) patients before therapy. Following treatment, the tyrosinase mRNA was detected in only one patient, while Melan A transcripts were still present in 14 patients. We suggest that this molecular assay can identify circulating melanoma cells that express melanoma-associated antigens and may provide an early indication of therapy effectiveness.

Running of high patient volume radiation oncology department during COVID-19 crisis in India: our institutional strategy

  • Gupta, Manoj;Ahuja, Rachit;Gupta, Sweety;Joseph, Deepa;Pasricha, Rajesh;Verma, Swati;Pandey, Laxman
    • Radiation Oncology Journal
    • /
    • 제38권2호
    • /
    • pp.93-98
    • /
    • 2020
  • Purpose: Due to COVID 19 pandemic, the treatment of cancer patients has become a dilemma for every oncologist. Cancer patients are at an increased risk of immunosuppression and have a higher risk to acquire any infection. There are individual experiences from some centers regarding the management of cancer patients during such a crisis. So we have developed our institutional strategy to balance between COVID and cancer management. Materials and Methods: Radiation Oncology departmental meeting was held to prepare a consensus document on Radiotherapy schedules and department functioning during this pandemic. Results: Strategies were taken in form of following areas were steps need to be taken to decrease risk of infection, categorise treatment on the basis of priority, radiotherapy schedules modification, academic meetings and management of COVID positive patient/personnel in Radiation Oncology department. Conclusion: We hope to strike the balance in overcoming both the battles and emerge as winners. Stringent long term follow up will be done for assessing the response or any unforeseen treatment related sequelae.

Clinical utility of CA-125 in the management of uterine carcinosarcoma

  • Matsuo, Koji;Ross, Malcolm S.;Yunokawa, Mayu;Johnson, Marian S.;Machida, Hiroko;Omatsu, Kohei;Klobocista, Merieme M.;Im, Dwight D.;Satoh, Shinya;Baba, Tsukasa;Ikeda, Yuji;Bush, Stephen H.;Hasegawa, Kosei;Blake, Erin A.;Takekuma, Munetaka;Shida, Masako;Nishimura, Masato;Adachi, Sosuke;Pejovic, Tanja;Takeuchi, Satoshi;Yokoyama, Takuhei;Ueda, Yutaka;Iwasaki, Keita;Miyake, Takahito M.;Yanai, Shiori;Nagano, Tadayoshi;Takano, Tadao;Shahzad, Mian MK;Ueland, Frederick R.;Kelley, Joseph L.;Roman, Lynda D.
    • Journal of Gynecologic Oncology
    • /
    • 제29권6호
    • /
    • pp.88.1-88.7
    • /
    • 2018